NIH-funded research R37 grant

Understanding how the gut protects itself from inflammation caused by TNF

Official title: Novel mechanisms protecting the gut from TNF

Funded at Weill Medical Coll of Cornell Univ · NIH-10890196 · Data updated 2026-11-12

This study is looking at how a special type of immune cell helps keep your gut healthy and protects it from damage caused by inflammation, which is important for people with conditions like inflammatory bowel disease (IBD).

Quick facts

Grant typeR37 grant
Study typeNIH-funded research
Funding institutionWeill Medical Coll of Cornell Univ
NIH-funded
Lab location1 site (New York, United States)
Project startJuly 18, 2023
Project endJune 30, 2028
Funding year2024
Award (this year)$651,105
NIH project number5R37AI174468-02
Project IDNIH-10890196 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals suffering from inflammatory bowel disease or related gastrointestinal conditions characterized by chronic inflammation.

Less likely to help

Patients with non-inflammatory gastrointestinal disorders or those without any gastrointestinal issues may not benefit from this research.

What this research studies

This research investigates the role of a specific type of immune cell, known as group 3 innate lymphoid cells (ILC3s), in protecting the intestinal lining from damage caused by tumor necrosis factor (TNF), a substance that can lead to chronic inflammation. The study aims to uncover the mechanisms by which ILC3s help maintain gut health and prevent inflammation, particularly in conditions like inflammatory bowel disease (IBD). By exploring how these cells produce protective substances, the research seeks to identify new therapeutic targets for improving gut health in affected patients.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that better protect the gut from inflammation and improve outcomes for patients with inflammatory bowel disease.

How similar studies have gone: Previous research has shown promising results in understanding immune cell functions in the gut, suggesting that this approach could yield significant insights and advancements.

Where this research is happening

  • Weill Medical Coll of Cornell Univ
    New York, United States
    Active

Researchers

  • Principal investigator: Sonnenberg, Gregory F — Weill Medical Coll of Cornell Univ
  • Study coordinator: Sonnenberg, Gregory F

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.